# Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial

> **NCT01506856** · PHASE2,PHASE3 · COMPLETED · sponsor: **Gynecologic Oncology Trial & Investigation Consortium** · enrollment: 655 (actual)

## Conditions studied

- Epithelial Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Carcinoma

## Interventions

- **DRUG:** Paclitaxel(intravenous) + Carboplatin(intravenous)
- **DRUG:** Paclitaxel(intravenous) + Carboplatin(intraperitoneal)

## Key facts

- **NCT ID:** NCT01506856
- **Lead sponsor:** Gynecologic Oncology Trial & Investigation Consortium
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 655 (ACTUAL)
- **Last updated:** 2023-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01506856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01506856, "Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01506856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*